Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052132689> ?p ?o ?g. }
- W2052132689 endingPage "e36170" @default.
- W2052132689 startingPage "e36170" @default.
- W2052132689 abstract "Despite the benefits of estrogen receptor (ER)-targeted endocrine therapies in breast cancer, many tumors develop resistance. MicroRNAs (miRNAs) have been suggested as promising biomarkers and we here evaluated whether a miRNA profile could be identified, sub-grouping ER+ breast cancer patients treated with adjuvant Tamoxifen with regards to probability of recurrence.Global miRNA analysis was performed on 152 ER+ primary tumors from high-risk breast cancer patients with an initial discovery set of 52 patients, followed by two independent test sets (N = 60 and N = 40). All patients had received adjuvant Tamoxifen as mono-therapy (median clinical follow-up: 4.6 years) and half had developed distant recurrence (median time-to-recurrence: 3.5 years). MiRNA expression was examined by unsupervised hierarchical clustering and supervised analysis, including clinical parameters as co-variables.The discovery set identified 10 highly significant miRNAs that discriminated between the patient samples according to outcome. However, the subsequent two independent test sets did not confirm the predictive potential of these miRNAs. A significant correlation was identified between miR-7 and the tumor grade. Investigation of the microRNAs with the most variable expression between patients in different runs yielded a list of 31 microRNAs, eight of which are associated with stem cell characteristics.Based on the large sample size, our data strongly suggests that there is no single miRNA profile predictive of outcome following adjuvant Tamoxifen treatment in a broad cohort of ER+ breast cancer patients. We identified a sub-group of Tamoxifen-treated breast cancer patients with miRNA-expressing tumors associated with cancer stem cell characteristics." @default.
- W2052132689 created "2016-06-24" @default.
- W2052132689 creator A5011720560 @default.
- W2052132689 creator A5050949885 @default.
- W2052132689 creator A5061533768 @default.
- W2052132689 creator A5065000450 @default.
- W2052132689 creator A5067719774 @default.
- W2052132689 creator A5082453853 @default.
- W2052132689 date "2012-05-18" @default.
- W2052132689 modified "2023-10-11" @default.
- W2052132689 title "Global MicroRNA Expression Profiling of High-Risk ER+ Breast Cancers from Patients Receiving Adjuvant Tamoxifen Mono-Therapy: A DBCG Study" @default.
- W2052132689 cites W1453600927 @default.
- W2052132689 cites W1648301895 @default.
- W2052132689 cites W1982535740 @default.
- W2052132689 cites W1995242599 @default.
- W2052132689 cites W2001711983 @default.
- W2052132689 cites W2021047213 @default.
- W2052132689 cites W2023940796 @default.
- W2052132689 cites W2030083012 @default.
- W2052132689 cites W2036502577 @default.
- W2052132689 cites W2039275665 @default.
- W2052132689 cites W2046240292 @default.
- W2052132689 cites W2054132739 @default.
- W2052132689 cites W2084400739 @default.
- W2052132689 cites W2085757352 @default.
- W2052132689 cites W2095510030 @default.
- W2052132689 cites W2096910745 @default.
- W2052132689 cites W2097951173 @default.
- W2052132689 cites W2099099087 @default.
- W2052132689 cites W2107277934 @default.
- W2052132689 cites W2118728607 @default.
- W2052132689 cites W2125545284 @default.
- W2052132689 cites W2128768066 @default.
- W2052132689 cites W2129087581 @default.
- W2052132689 cites W2146194560 @default.
- W2052132689 cites W2150536104 @default.
- W2052132689 cites W2166938936 @default.
- W2052132689 cites W2170179858 @default.
- W2052132689 cites W2171583319 @default.
- W2052132689 doi "https://doi.org/10.1371/journal.pone.0036170" @default.
- W2052132689 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3356496" @default.
- W2052132689 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22623953" @default.
- W2052132689 hasPublicationYear "2012" @default.
- W2052132689 type Work @default.
- W2052132689 sameAs 2052132689 @default.
- W2052132689 citedByCount "52" @default.
- W2052132689 countsByYear W20521326892012 @default.
- W2052132689 countsByYear W20521326892013 @default.
- W2052132689 countsByYear W20521326892014 @default.
- W2052132689 countsByYear W20521326892015 @default.
- W2052132689 countsByYear W20521326892016 @default.
- W2052132689 countsByYear W20521326892017 @default.
- W2052132689 countsByYear W20521326892018 @default.
- W2052132689 countsByYear W20521326892019 @default.
- W2052132689 countsByYear W20521326892020 @default.
- W2052132689 countsByYear W20521326892021 @default.
- W2052132689 countsByYear W20521326892022 @default.
- W2052132689 crossrefType "journal-article" @default.
- W2052132689 hasAuthorship W2052132689A5011720560 @default.
- W2052132689 hasAuthorship W2052132689A5050949885 @default.
- W2052132689 hasAuthorship W2052132689A5061533768 @default.
- W2052132689 hasAuthorship W2052132689A5065000450 @default.
- W2052132689 hasAuthorship W2052132689A5067719774 @default.
- W2052132689 hasAuthorship W2052132689A5082453853 @default.
- W2052132689 hasBestOaLocation W20521326891 @default.
- W2052132689 hasConcept C104317684 @default.
- W2052132689 hasConcept C121608353 @default.
- W2052132689 hasConcept C126322002 @default.
- W2052132689 hasConcept C143998085 @default.
- W2052132689 hasConcept C145059251 @default.
- W2052132689 hasConcept C2777176818 @default.
- W2052132689 hasConcept C2777982462 @default.
- W2052132689 hasConcept C530470458 @default.
- W2052132689 hasConcept C55493867 @default.
- W2052132689 hasConcept C60644358 @default.
- W2052132689 hasConcept C71924100 @default.
- W2052132689 hasConcept C84606932 @default.
- W2052132689 hasConcept C86803240 @default.
- W2052132689 hasConceptScore W2052132689C104317684 @default.
- W2052132689 hasConceptScore W2052132689C121608353 @default.
- W2052132689 hasConceptScore W2052132689C126322002 @default.
- W2052132689 hasConceptScore W2052132689C143998085 @default.
- W2052132689 hasConceptScore W2052132689C145059251 @default.
- W2052132689 hasConceptScore W2052132689C2777176818 @default.
- W2052132689 hasConceptScore W2052132689C2777982462 @default.
- W2052132689 hasConceptScore W2052132689C530470458 @default.
- W2052132689 hasConceptScore W2052132689C55493867 @default.
- W2052132689 hasConceptScore W2052132689C60644358 @default.
- W2052132689 hasConceptScore W2052132689C71924100 @default.
- W2052132689 hasConceptScore W2052132689C84606932 @default.
- W2052132689 hasConceptScore W2052132689C86803240 @default.
- W2052132689 hasIssue "5" @default.
- W2052132689 hasLocation W20521326891 @default.
- W2052132689 hasLocation W20521326892 @default.
- W2052132689 hasLocation W20521326893 @default.
- W2052132689 hasLocation W20521326894 @default.
- W2052132689 hasLocation W20521326895 @default.
- W2052132689 hasLocation W20521326896 @default.